Myriad Genetics Inc (MYGN)
47.37
+1.02 +2.20%
NASDAQ
Sep 18, 15:17
Delayed 2m
USD
View All Key Stats
MYGN Key Stats
| Income Statement | |
| Revenue (TTM) | 772.60M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.84 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 131.10M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 76.50% |
| Profit Margin (Quarterly) | 3.34% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 3.359B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.408 |
| PE Ratio (TTM) | 25.74 |
| Price to Book Value | 3.482 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 46.10M |
| Return on Equity (TTM) | Upgrade |
View All MYGN News
MYGN News
-
WireHeadlineTime (ET)
-
Yahoo09/18 08:06
-
Yahoo09/05 22:16
-
MT Newswires09/05 09:32
-
SA Breaking News09/05 08:35
-
Globe Newswire08/31 07:05
-
Yahoo08/25 08:05
-
Yahoo08/24 18:48
-
Yahoo08/23 11:32
-
Yahoo08/23 10:17
-
Yahoo08/23 08:23
View All Events
MYGN Events
| Date | Type | Description |
|---|---|---|
| 11/07/2018 16:30 EST | Misc | Myriad Genetics Inc First Quarter Earnings Conference Call in 2019 |
| 11/07/2018 | Earnings | Myriad Genetics Inc First Quarter Earnings in 2019 Release |
| 08/24/2018 | Misc | Myriad Genetics Inc Annual Report in 2018 |
| 08/14/2018 16:30 EDT | Misc | Myriad Genetics Inc Fourth Quarter Earnings Conference Call in 2018 |
| 08/14/2018 | Earnings | Myriad Genetics Inc Fourth Quarter Earnings Results in 2018 |
| 05/28/2018 | Misc | Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc |
| 05/08/2018 07:30 EDT | Misc | Myriad Genetics Inc Third Quarter Earnings Conference Call in 2018 |
| 05/08/2018 | Earnings | Myriad Genetics Inc Third Quarter Earnings Results in 2018 |
| 02/06/2018 16:30 EST | Misc | Myriad Genetics Inc Second Quarter Earnings Conference Call in 2018 |
| 02/06/2018 | Earnings | Myriad Genetics Inc Second Quarter Earnings Results in 2018 |
MYGN Fundamentals
Income Statement View Statement
MYGN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MYGN One Page Reports
- One Page Report Download
MYGN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 47.37 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.myriad.com
- Investor Relations URL: https://myriad.com/news-center/investor-information/
- HQ State/Province: Utah
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Small Cap/Growth
- Next Earnings Release: Nov. 07, 2018
- Last Earnings Release: Aug. 14, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.
MYGN Excel Add-In Codes
- Name: =YCI("MYGN","name")
- Description: =YCI("MYGN","description")
- Sector: =YCI("MYGN","sector")
- Industry: =YCI("MYGN","industry")
- Est. Current Fiscal Year End: =YCI("MYGN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MYGN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MYGN Tweets Stocktwits
Advertisement
